FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116168134> ?p ?o ?g. }

• W2116168134 endingPage "950" @default.
• W2116168134 startingPage "944" @default.
• W2116168134 abstract "Adult T-cell leukemia/lymphoma (ATL) is caused by human T-lymphotrophic virus type 1 infection and is one of the most refractory malignant T-cell lymphomas. Improvement of ATL therapy options requires the establishment of appropriate ATL animal models. In this study, we successfully generated an ATL mouse model by xenotransplantation of primary peripheral blood mononuclear cells (PBMCs) isolated from ATL patients (ATL cells) into nonobese diabetic/severe combined immunodeficiency/Jak3-null mice (NOJ mice). To generate the model, the ATL S1T cell line was subcutaneously injected into mice. Primary ATL cells were then transplanted subcutaneously, intraperitoneally, or intravenously. ATL cells infiltrated multiple organs, and elevated human soluble interleukin 2 receptor (IL-2R) levels were detected in peripheral blood. Injection of one million primary ATL cells was needed for successful engraftment into host mice. Thawed cells, frozen long-term in liquid nitrogen, could also be transplanted; however, more cells were required to achieve similar results. The median mouse survival time was proportional to the number of cells injected. Successful secondary transplantation of ATL cells from one NOJ mouse into another was achieved and confirmed by T-cell receptor analysis. Finally, we examined the effects of the antioxide pyrrolidine dithiocarbamate (PDTC) as an antitumor agent in vivo. PDTC administration inhibited the increase of soluble IL-2R and improved mouse survival, suggesting that this compound has potential as an anti-ATL agent. We demonstrated that ATL cells could be stably xenotransplanted into NOJ mice using primary cells. This model will be useful in the establishment of novel therapies to treat ATL." @default.
• W2116168134 created "2016-06-24" @default.
• W2116168134 creator A5002354175 @default.
• W2116168134 creator A5006732792 @default.
• W2116168134 creator A5012338762 @default.
• W2116168134 creator A5012931208 @default.
• W2116168134 creator A5019982067 @default.
• W2116168134 creator A5031824609 @default.
• W2116168134 creator A5040927651 @default.
• W2116168134 creator A5044838015 @default.
• W2116168134 creator A5047054094 @default.
• W2116168134 creator A5047973660 @default.
• W2116168134 creator A5048147097 @default.
• W2116168134 creator A5071120852 @default.
• W2116168134 creator A5071684387 @default.
• W2116168134 creator A5072650136 @default.
• W2116168134 creator A5075358038 @default.
• W2116168134 creator A5077752560 @default.
• W2116168134 creator A5078286851 @default.
• W2116168134 date "2015-11-01" @default.
• W2116168134 modified "2023-09-24" @default.
• W2116168134 title "A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent" @default.
• W2116168134 cites W1523967295 @default.
• W2116168134 cites W1524794013 @default.
• W2116168134 cites W2032176053 @default.
• W2116168134 cites W2058015212 @default.
• W2116168134 cites W2061440903 @default.
• W2116168134 cites W2074571719 @default.
• W2116168134 cites W2082376664 @default.
• W2116168134 cites W2094830334 @default.
• W2116168134 cites W2099464793 @default.
• W2116168134 cites W2101322566 @default.
• W2116168134 cites W2121960517 @default.
• W2116168134 cites W2129338773 @default.
• W2116168134 cites W2158552371 @default.
• W2116168134 cites W2163653305 @default.
• W2116168134 cites W2318772898 @default.
• W2116168134 cites W2321606182 @default.
• W2116168134 cites W84044824 @default.
• W2116168134 cites W88146136 @default.
• W2116168134 doi "https://doi.org/10.1016/j.exphem.2015.06.303" @default.
• W2116168134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26169955" @default.
• W2116168134 hasPublicationYear "2015" @default.
• W2116168134 type Work @default.
• W2116168134 sameAs 2116168134 @default.
• W2116168134 citedByCount "4" @default.
• W2116168134 countsByYear W21161681342018 @default.
• W2116168134 countsByYear W21161681342019 @default.
• W2116168134 countsByYear W21161681342021 @default.
• W2116168134 countsByYear W21161681342022 @default.
• W2116168134 crossrefType "journal-article" @default.
• W2116168134 hasAuthorship W2116168134A5002354175 @default.
• W2116168134 hasAuthorship W2116168134A5006732792 @default.
• W2116168134 hasAuthorship W2116168134A5012338762 @default.
• W2116168134 hasAuthorship W2116168134A5012931208 @default.
• W2116168134 hasAuthorship W2116168134A5019982067 @default.
• W2116168134 hasAuthorship W2116168134A5031824609 @default.
• W2116168134 hasAuthorship W2116168134A5040927651 @default.
• W2116168134 hasAuthorship W2116168134A5044838015 @default.
• W2116168134 hasAuthorship W2116168134A5047054094 @default.
• W2116168134 hasAuthorship W2116168134A5047973660 @default.
• W2116168134 hasAuthorship W2116168134A5048147097 @default.
• W2116168134 hasAuthorship W2116168134A5071120852 @default.
• W2116168134 hasAuthorship W2116168134A5071684387 @default.
• W2116168134 hasAuthorship W2116168134A5072650136 @default.
• W2116168134 hasAuthorship W2116168134A5075358038 @default.
• W2116168134 hasAuthorship W2116168134A5077752560 @default.
• W2116168134 hasAuthorship W2116168134A5078286851 @default.
• W2116168134 hasConcept C126322002 @default.
• W2116168134 hasConcept C137061746 @default.
• W2116168134 hasConcept C150903083 @default.
• W2116168134 hasConcept C202751555 @default.
• W2116168134 hasConcept C203014093 @default.
• W2116168134 hasConcept C207001950 @default.
• W2116168134 hasConcept C2776913467 @default.
• W2116168134 hasConcept C2776914184 @default.
• W2116168134 hasConcept C2777730290 @default.
• W2116168134 hasConcept C2778442404 @default.
• W2116168134 hasConcept C2778461978 @default.
• W2116168134 hasConcept C2779338263 @default.
• W2116168134 hasConcept C2780983412 @default.
• W2116168134 hasConcept C2911091166 @default.
• W2116168134 hasConcept C502942594 @default.
• W2116168134 hasConcept C55493867 @default.
• W2116168134 hasConcept C71924100 @default.
• W2116168134 hasConcept C86803240 @default.
• W2116168134 hasConcept C98274493 @default.
• W2116168134 hasConceptScore W2116168134C126322002 @default.
• W2116168134 hasConceptScore W2116168134C137061746 @default.
• W2116168134 hasConceptScore W2116168134C150903083 @default.
• W2116168134 hasConceptScore W2116168134C202751555 @default.
• W2116168134 hasConceptScore W2116168134C203014093 @default.
• W2116168134 hasConceptScore W2116168134C207001950 @default.
• W2116168134 hasConceptScore W2116168134C2776913467 @default.
• W2116168134 hasConceptScore W2116168134C2776914184 @default.
• W2116168134 hasConceptScore W2116168134C2777730290 @default.
• W2116168134 hasConceptScore W2116168134C2778442404 @default.
• W2116168134 hasConceptScore W2116168134C2778461978 @default.

• next